Is gout a risk equivalent to diabetes for stroke and myocardial infarction? A retrospective claims database study
- PMID: 29041963
- PMCID: PMC5646136
- DOI: 10.1186/s13075-017-1427-5
Is gout a risk equivalent to diabetes for stroke and myocardial infarction? A retrospective claims database study
Abstract
Background: Gout is a risk factor for cardiovascular disease, but associations with specific cardiovascular outcomes, myocardial infarction (MI), and stroke are unclear. Our objective in the present study was to assess whether gout is as strong a risk factor as diabetes mellitus (DM) for incident MI and incident stroke.
Methods: In this retrospective study, we used U.S. claims data from 2007 to 2010 that included a mix of private and public health plans. Four mutually exclusive cohorts were identified: (1) DM only, (2) gout only, (3) gout and DM, and (4) neither gout nor DM. Outcomes were acute MI or stroke with hospitalization. We compared the age- and sex-specific rates of incident MI and stroke across the four cohorts and assessed multivariable-adjusted HRs.
Results: In this study, 232,592 patients had DM, 71,755 had gout, 23,261 had both, and 1,010,893 had neither. The incidence of acute MI was lowest in patients with neither gout nor DM, followed by patients with gout alone, DM alone, and both. Among men >80 years of age, the respective rates/1000 person-years were 14.6, 25.4, 27.7, and 37.4. Similar trends were noted for stroke and in women. Compared with DM only, gout was associated with a significantly lower adjusted HR of incident MI (HR 0.81, 95% CI 0.76-0.87) but a similar risk of stroke (HR 1.02, 95% CI 0.95-1.10). Compared with patients with DM only, patients with both gout and DM had higher HRs for incident MI and stroke (respectively, HR 1.35, 95% CI 1.25-1.47; HR 1.42, 95% CI 1.29-1.56).
Conclusions: Gout is a risk equivalent to DM for incident stroke but not for incident MI. Having both gout and DM confers incremental risk compared with DM alone for both incident MI and stroke.
Keywords: Diabetes; Gout; Myocardial infarction; Risk equivalent; Stroke.
Conflict of interest statement
Authors’ information
JAS has served as the cochair of the gout working group of the Outcome Measures in Rheumatology (OMERACT) initiative.
Ethics approval and consent to participate
The institutional review board (IRB) at the University of Alabama at Birmingham approved this study, and all investigations were conducted in conformity with ethical principles of research. The IRB waived the need for written informed consent for this retrospective database study.
Consent for publication
Not applicable.
Competing interests
JAS has received research grants from Takeda Pharmaceuticals and Savient Pharmaceuticals and consultant fees from Savient Pharmaceuticals, Takeda Pharmaceuticals, Regeneron Pharmaceuticals, Merz, Bioibérica, Crealta Pharmaceuticals, Allergan, WebMD, UBM LLC, and the American College of Rheumatology (ACR). JAS serves as the principal investigator for an investigator-initiated study funded by Horizon Pharma through a grant to DINORA, Inc., a 501(c)(3) entity. JAS is a member of the executive committee of OMERACT, an organization that develops outcome measures in rheumatology and receives arm’s-length funding from 36 companies; a member of the ACR Annual Meeting Planning Committee; chair of the ACR Meet the Professor, Workshop, and Study Group Subcommittee; and a member of the Veterans Affairs Rheumatology Field Advisory Committee. JRC has received research grant funding via the University of Alabama at Birmingham and consulting monies for unrelated work from AbbVie, Amgen, Bristol-Myers Squibb, Janssen, Pfizer, Roche, and UCB. The other authors declare that they have no competing interests. None of the authors have any other nonfinancial disclosures.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures

Similar articles
-
Comparative trends in the incidence of hospitalized myocardial infarction and coronary heart disease in adults with and without diabetes mellitus in Western Australia from 1998 to 2010.Circ Cardiovasc Qual Outcomes. 2014 Sep;7(5):708-17. doi: 10.1161/CIRCOUTCOMES.114.000952. Epub 2014 Aug 26. Circ Cardiovasc Qual Outcomes. 2014. PMID: 25160842
-
Allopurinol use and the risk of acute cardiovascular events in patients with gout and diabetes.BMC Cardiovasc Disord. 2017 Mar 14;17(1):76. doi: 10.1186/s12872-017-0513-6. BMC Cardiovasc Disord. 2017. PMID: 28288564 Free PMC article.
-
Gout as a risk factor for myocardial infarction and stroke in England: evidence from record linkage studies.Rheumatology (Oxford). 2013 Dec;52(12):2251-9. doi: 10.1093/rheumatology/ket293. Epub 2013 Sep 17. Rheumatology (Oxford). 2013. PMID: 24046469
-
Risk of myocardial infarction and heart failure in gout patients: a systematic review and meta-analysis.J Cardiothorac Surg. 2025 Jan 17;20(1):69. doi: 10.1186/s13019-024-03209-5. J Cardiothorac Surg. 2025. PMID: 39825406 Free PMC article.
-
Antipsychotic drug use and risk of stroke and myocardial infarction: a systematic review and meta-analysis.BMC Psychiatry. 2019 Jun 20;19(1):189. doi: 10.1186/s12888-019-2177-5. BMC Psychiatry. 2019. PMID: 31221107 Free PMC article.
Cited by
-
Gout and the risk of myocardial infarction in older adults: a study of Medicare recipients.Arthritis Res Ther. 2018 Jun 1;20(1):109. doi: 10.1186/s13075-018-1606-z. Arthritis Res Ther. 2018. PMID: 29859125 Free PMC article.
-
An assessment of cardiovascular disease hospitalizations and disparities by race in patients with rheumatic disease hospitalizations in Alaska, 2015-2018.BMC Rheumatol. 2024 Feb 18;8(1):7. doi: 10.1186/s41927-024-00377-8. BMC Rheumatol. 2024. PMID: 38369541 Free PMC article.
-
The risk and severity of stroke in patients with atrial fibrillation and gout: A National Representative Database study.J Arrhythm. 2021 Jan 25;37(2):394-399. doi: 10.1002/joa3.12505. eCollection 2021 Apr. J Arrhythm. 2021. PMID: 33850581 Free PMC article.
-
Reduced Incidence of Stroke in Patients with Gout Using Benzbromarone.J Pers Med. 2022 Jan 2;12(1):28. doi: 10.3390/jpm12010028. J Pers Med. 2022. PMID: 35055342 Free PMC article.
-
Association between serum urate levels and all-cause mortality, cardiovascular and renal outcomes among gout patients in Singapore.BMC Rheumatol. 2024 Dec 20;8(1):71. doi: 10.1186/s41927-024-00449-9. BMC Rheumatol. 2024. PMID: 39707504 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical